Challenges and Opportunities for Oligonucleotide-Based Therapeutics by Antisense and RNA Interference Mechanisms

  • Ramon Eritja, Montserrat Terrazas, Santiago Grijalvo, Anna Aviñó, Adele Alagia, Sónia Pérez-Rentero, Juan Carlos Morales
  • January 2014, Springer Science + Business Media
  • DOI: 10.1007/978-3-642-54452-1_13

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Ramon Eritja